Can AI replace your Doctor's Go-To medical guides? a new study puts four chatbots to the test.

NCT ID NCT07199231

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 19, 2026 · Updated 4 times

Summary

This study enrolls 20 medical residents to test an AI tool called OpenEvidence alongside trusted resources like UpToDate. The goal is to see if the AI helps them make good clinical decisions and how it compares to ChatGPT, Claude, and Gemini. Experts will rate the AI outputs for accuracy, completeness, and safety. This is a knowledge-gathering study, not a treatment trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Post-graduate trainees in Internal Medicine, Family Medicine, Adult Psychiatry, or Child Psychiatry

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Active trainees PGY-1 through PGY-6 in Internal Medicine, Family Medicine, Adult Psychiatry, or Child Psychiatry at Cambridge Health Alliance * Must agree to the study protocol requirements outlined in the study description. Exclusion Criteria: * Anyone who does not meet inclusion criteria * Residents who plan to leave CHA prior to the end of the study collection period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ai (artificial intelligence) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cambridge Health Alliance

    Cambridge, Massachusetts, 02193, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.